Zimmer Biomet Appoints Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer

Rhea-AI Summary

Zimmer Biomet (NYSE and SIX: ZBH) has appointed Jehanzeb Noor as Senior Vice President, Chief Strategy, Innovation and Business Development Officer, reporting to CEO Ivan Tornos. In his new role, Noor will lead strategy development, oversee M&A activities including the Paragon 28 acquisition integration, and manage research and product development organizations. He will also serve as Chief of Staff to the CEO.

Noor joins from Trivium, where he served as President and Managing Director for Europe, Africa, and Asia, leading transformation initiatives for margin and cash expansion. His previous experience includes serving as CEO of Smiths Medical and roles at Amcor, McKinsey, Ford Motor Company, and Constellation Energy. Noor holds multiple degrees from MIT, including an MS in Product Development and BS degrees in Finance and Mechanical Engineering.

Positive

• Strategic hire brings extensive healthcare and transformation experience
• Will oversee pending Paragon 28 acquisition integration
• Strong educational background with multiple MIT degrees
• Proven track record in operational excellence and margin expansion

Negative

• None.

WARSAW, Ind., Feb. 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Jehanzeb Noor is joining the Company as Senior Vice President, Chief Strategy, Innovation and Business Development Officer. He will report to Ivan Tornos, President and CEO of Zimmer Biomet.

In his new role, Mr. Noor will be responsible for leading strategy development and execution and all facets of M&A, including the integration for our pending acquisition of Paragon 28. In addition, he will have oversight of the research and product development organizations, inclusive of new product and service development, partnership and ecosystem development, and platform technologies. He will also serve as the Chief of Staff to the CEO.

"I'm thrilled to welcome Jehanzeb to Zimmer Biomet," said Mr. Tornos. "Over the course of his career, Jehanzeb has consistently demonstrated an impressive track record of significantly improving execution, culture and results. As we continue to boldly execute against our strategy and pursue innovation, I am confident Jehanzeb will be instrumental to our long-term success and deliver value for patients, surgeons, health systems and shareholders."

Prior to Zimmer Biomet, Mr. Noor served as President and Managing Director for Europe, Africa, and Asia at Trivium, where he led Trivium's top & bottom-line transformation to drive operational excellence for margin and cash expansion. Prior to Trivium, Mr. Noor was CEO of Smiths Medical for three years and also held roles of increasing responsibility at Amcor, McKinsey, Ford Motor Company, and Constellation Energy Commodities Group. 

Mr. Noor holds a Master of Science with a focus on Product Development, a Bachelor of Science in Finance and a Bachelor of Science in Mechanical Engineering, all from the Massachusetts Institute of Technology (MIT).

About Zimmer Biomet
Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.

With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers. Our legacy continues to come to life today through our progressive culture of evolution and innovation.

For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com or follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X / Twitter at www.twitter.com/zimmerbiomet.

Media	Investors
Heather Zoumas-Lubeski	David DeMartino
445-248-0577	646-531-6115
heather.zoumaslubeski@zimmerbiomet.com	david.demartino@zimmerbiomet.com
	Zach Weiner
	908-591-6955
	zach.weiner@zimmerbiomet.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/zimmer-biomet-appoints-jehanzeb-noor-as-senior-vice-president-chief-strategy-innovation-and-business-development-officer-302386664.html

SOURCE Zimmer Biomet Holdings, Inc.

FAQ

What are Jehanzeb Noor's main responsibilities at Zimmer Biomet (ZBH)?

As SVP and Chief Strategy Officer, Noor will lead strategy development, M&A activities including Paragon 28 integration, oversee R&D, and serve as Chief of Staff to the CEO.

How will the new Chief Strategy Officer appointment impact ZBH's innovation strategy?

Noor will oversee research, product development, partnership development, and platform technologies, focusing on driving innovation and long-term success.

What experience does Jehanzeb Noor bring to Zimmer Biomet (ZBH)?

Noor was President at Trivium leading transformation initiatives, CEO of Smiths Medical, and held roles at Amcor, McKinsey, Ford Motor Company, with MIT degrees in Product Development, Finance, and Engineering.

How does ZBH's new Chief Strategy Officer appointment align with their acquisition strategy?

Noor will lead M&A activities and specifically oversee the integration of the pending Paragon 28 acquisition, supporting ZBH's strategic growth initiatives.